SV Health Investors
Nikola Trbovic is a seasoned professional in the biotechnology and investment sectors, currently serving as a Partner at SV Health Investors since January 2022. With extensive experience on various boards, Nikola has contributed to organizations such as Triplet Therapeutics, TRex Bio, Jnana Therapeutics, Arrakis Therapeutics, Palleon Pharmaceuticals, Nimbus Therapeutics, and Lodo Therapeutics Corporation from 2019 to 2021. Previously, Nikola held the role of Partner at Pfizer Ventures from September 2014 to December 2021, focusing on equity investments in early-stage biotech companies aimed at developing transformative therapeutics. Nikola earned a Ph.D. in Biophysics and Biochemistry from Columbia University between 2005 and 2009.
This person is not in the org chart
This person is not in any offices
SV Health Investors
SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm.Their goal is to transform healthcare – one investment at a time – by supporting the entrepreneurs who create and build breakthrough companies and treatments.With over $2 billion in capital under management inseven private healthcare funds, a 20-year track record in the US and Europe and offices in Boston, San Francisco and London, SV Health Investors drives game-changing innovation.